{"title": "Immuni Therapeutics abre una ronda de 2 millones en Capital Cell para desarrollar RUTI\u00ae como vacuna preventiva ante la COVID-19 y nuevas pandemias", "author": null, "url": null, "hostname": null, "description": "Immuni Therapeutics abre una ronda de 2 millones en Capital Cell para desarrollar RUTI\u00ae como vacuna preventiva ante la COVID-19 y nuevas pandemias", "sitename": null, "date": "2020-07-14", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La compa\u00f1\u00eda biotecnol\u00f3gica Archivel Farma ha creado una nueva compa\u00f1\u00eda,Immuni Therapeutics, para desarrollar la vacuna RUTI\u00ae como una vacuna eficaz contra infecciones v\u00edricas (incluyendo COVID-19) basada en la inmunidad innata entrenada. La inmunidad innata es la primera l\u00ednea de respuesta a pat\u00f3genos desconocidos, es inespec\u00edfica y no genera anticuerpos. Algunos productos, como la vacuna RUTI\u00ae, estimulan la inmunidad innata y la dotan de memoria, la \u201centrenan\u201d para generar una mejor y m\u00e1s r\u00e1pida respuesta, por lo que RUTI\u00ae podr\u00eda ser la base de vacunas antiv\u00edricas de amplio espectro y de primer recurso contra infecciones nuevas.\nDe la mano de RUTI\u00ae y en el contexto de la crisis de la COVID-19, Immuni Therapeutics podr\u00eda ser la primera empresa a nivel mundial que consigue la aprobaci\u00f3n de una vacuna contra una infecci\u00f3n v\u00edrica basada en el mecanismo de acci\u00f3n de la inmunidad entrenada. Un aut\u00e9ntico cambio de paradigma alternativo y complementario al de la vacunaci\u00f3n cl\u00e1sica, espec\u00edfica, basada en la generaci\u00f3n de anticuerpos. Esta nueva opci\u00f3n terap\u00e9utica podr\u00eda emplearse como primer recurso en caso de pandemias provocadas por virus nuevos o en mutaciones de virus pand\u00e9micos que hacen que las vacunas existentes pierdan su eficacia inicial. Tambi\u00e9n tendr\u00eda aplicaci\u00f3n como refuerzo en poblaciones que no responden con eficacia a las vacunas espec\u00edficas o en vacunas que generan anticuerpos que se pierden en poco tiempo (como podr\u00eda ser el caso de la COVID-19).\nPara demostrar la validez cl\u00ednica de esta aproximaci\u00f3n y para preparar el marco regulatorio y la capacidad productiva, Archivel otorgar\u00e1 una licencia exclusiva de la RUTI\u00ae a la nueva compa\u00f1\u00eda para su desarrollo como vacuna antiv\u00edrica de primer recurso y amplio espectro. La inversi\u00f3n inicial requerida en este proceso es de 2 millones de euros. Para conseguirlos, Immuni Therapeutics ha abierto una ronda de financiaci\u00f3n dirigida a inversores privados, incluyendo la plataforma de inversi\u00f3n Capital Cell. Con esta inversi\u00f3n se podr\u00e1n financiar hasta 3 ensayos cl\u00ednicos de eficacia en diferentes pa\u00edses del mundo y aumentar la capacidad de producci\u00f3n de la vacuna (actualmente de 2 millones de unidades anuales) para preparar el despliegue global de la vacuna a partir de 2022.\nRUTI\u00ae en el contexto de la COVID-19 y otras enfermedades infecciosas\nEl virus SARS-CoV-2 que provoca la enfermedad COVID-19 ha infectado a m\u00e1s de 13 millones personas en todo el mundo, y ya han fallecido m\u00e1s de 500.000 personas. Globalmente, las enfermedades infecciosas como el VIH, la tuberculosis, la hepatitis viral, la malaria, las enfermedades tropicales desatendidas y las infecciones de transmisi\u00f3n sexual matar\u00e1n a unos 4 millones de personas en 2020.\nPara estas patolog\u00edas, las vacunas son un instrumento fundamental en la estrategia de salud p\u00fablica y constituyen uno de los m\u00e9todos m\u00e1s coste-eficientes. En esencia, las vacunas son agentes preventivos que se administran a personas sanas y preparan el sistema inmune para responder a una infecci\u00f3n. Adem\u00e1s, uno de sus principales beneficios es que, adem\u00e1s de proteger a la persona vacunada, tambi\u00e9n protegen a las que forman parte de la misma comunidad.\nEn estos momentos varios grupos cient\u00edficos est\u00e1n investigando si la vacuna BCG, la \u00fanica vacuna contra la tuberculosis aprobada, tambi\u00e9n puede aliviar la infecci\u00f3n por coronavirus gracias a su capacidad de estimular la respuesta innata entrenada. En concreto, hay m\u00e1s de 17 ensayos cl\u00ednicos en curso (con m\u00e1s de 15.000 voluntarios implicados) que est\u00e1n explorando la eficacia de la BCG para disminuir el impacto de la COVID-19 en individuos con elevado riesgo de infecci\u00f3n (fundamentalmente profesionales sanitarios).\nLos datos precl\u00ednicos y cl\u00ednicos disponibles sobre RUTI\u00ae, concebida como vacuna contra la tuberculosis al igual que la BCG, sugieren que tiene un perfil de potencia y seguridad superior a la BCG y que genera tambi\u00e9n una estimulaci\u00f3n de respuesta inmune entrenada. La respuesta innata entrenada que inducen tanto la BCG como la RUTI\u00ae permitir\u00eda reducir la exposici\u00f3n al virus y modular la respuesta inmune, de modo que las personas vacunadas que aun as\u00ed se infecten no progresen hacia la fase m\u00e1s inflamatoria y cr\u00edtica de la enfermedad. Si esta hip\u00f3tesis se valida cl\u00ednicamente con los estudios que realizar\u00e1 Immuni Therapeutics con RUTI\u00ae durante los pr\u00f3ximos 9 meses, RUTI\u00ae ser\u00eda la mejor opci\u00f3n terap\u00e9utica disponible como alternativa o complemento a las vacunas espec\u00edficas dirigidas a la generaci\u00f3n de anticuerpos. La compa\u00f1\u00eda estar\u00e1 en condiciones de suministrar vacuna a escala global en 2022.\nSobre Archivel Farma- IMMUNI Therapeutics\nARCHIVEL FARMA es una compa\u00f1\u00eda biotecnol\u00f3gica fundada en 2005 en Barcelona que trabaja en el desarrollo de la vacuna RUTI\u00ae, un producto biol\u00f3gico ideado por el Dr. Pere Joan Cardona, del Institut d\u2019Investigaci\u00f3 Germans Trias i Pujol, para tratar la tuberculosis (especialmente, la\ntuberculosis resistente a los antibi\u00f3ticos) y otras enfermedades susceptibles de intervenciones inmunomoduladoras. El objetivo de la compa\u00f1\u00eda es desarrollar la vacuna RUTI\u00ae para diferentesindicaciones hasta fases cl\u00ednicas avanzadas y licenciarla a compa\u00f1\u00edas del sector farmac\u00e9utico que la puedan hacer llegar al mercado haci\u00e9ndola accesible al mayor n\u00famero de personas. Cuenta con un equipo de m\u00e1s de 20 profesionales y tiene su propia planta de fabricaci\u00f3n certificada con las GMP (Good Manufacturing Practices) para la producci\u00f3n y liberaci\u00f3n de productos en investigaci\u00f3n est\u00e9riles y biol\u00f3gicos, su acondicionamiento y control de calidad. Para desarrollar la vacuna RUTI\u00ae para Covid-19 y otras infecciones virales, ARCHIVEL FARMA ha constituido IMMUNI THERAPEUTICS, que ostentar\u00e1 los derechos de desarrollo y comercializaci\u00f3n de la vacuna para esta indicaci\u00f3n.\nSobre los portavoces\nOlga Ru\u00e9. CEO Archivel Farma S.L., una compa\u00f1\u00eda biofarmac\u00e9utica ubicada en Badalona que est\u00e1 desarrollando RUTI\u00ae, una vacuna terap\u00e9utica candidata contra la tuberculosis y otras enfermedades susceptibles de intervenciones inmunomoduladoras. Actualmente lidera la estrategia de investigaci\u00f3n y desarrollo de negocio de la compa\u00f1\u00eda.\nLuis Ruiz. CEO Immuni Therapeutics S.L. Doctor en Biolog\u00eda Molecular. Es uno de los fundadores de Catalonia Bio. Actualmente dirige Aquil\u00f3n Cyl (una empresa de I+D veterin\u00e0ria Spin-off de la Universidad de Le\u00f3n) y Leukos Biotech (Spinoff del Institut Josep Carreras contra la Leuc\u00e8mia). Fue Director General de Archivel en 2011-2012.\nPere Joan Cardona. Investigador del Servicio de Microbiolog\u00eda del Hospital Germans Trias i Pujol-IGTP. Especialista en Microbiolog\u00eda y Parasitolog\u00eda. Miembro del CIBER Enfermedades Respiratorias. Investiga en tuberculosis en la\n[Unidad de Tuberculosis Experimental](http://unitatdetuberculosiexperimental.wordpress.com/%22%20%5Ct%20%22_blank) (UTE) y es el inventor de la vacuna RUTI\u00ae y Manremyc.\nSobre Capital Cell\nCAPITAL CELL es la primera plataforma de inversi\u00f3n online de Europa especializada en Salud y Biotecnolog\u00eda. Fundada en 2015, la compa\u00f1\u00eda est\u00e1 liderada por Daniel Oliver y ha canalizado hasta el momento 14,8 millones de inversi\u00f3n directa -un total de 29 millones de euros de coinversi\u00f3n-, para 38 empresas. CAPITAL CELL analiza oportunidades de inversi\u00f3n y realiza la due dilligence de las compa\u00f1\u00edas antes de lanzar las rondas de inversi\u00f3n a trav\u00e9s de su plataforma.\nFoto:", "language": null, "image": null, "pagetype": null, "links": ["http://biotech-spain.com/en/", null, "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/directory", "http://biotech-spain.com/en/admin/", "http://biotech-spain.com/en/contact", "/en", "/es", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/articles?category=venture-capital", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles?category=research-services-and-supp", "http://biotech-spain.com/en/articles?category=healthy", "http://biotech-spain.com/en/articles?category=research-network", "http://biotech-spain.com/en/articles?category=private-investor", "http://biotech-spain.com/en/articles?category=immunology", "http://biotech-spain.com/en/articles?category=infections", "http://biotech-spain.com/en/articles?category=investment-funds", "http://biotech-spain.com/en/articles?category=venture-capital-manageme", "http://biotech-spain.com/en/articles?category=drug-development", "http://biotech-spain.com/en/articles?category=biodrugs", "http://biotech-spain.com/en/articles/immuni-therapeutics-abre-una-ronda-de-2-millones-en-capital-cell-para-desarrollar-ruti-como-vacuna-preventiva-ante-la-covid-19-y-nuevas-pandemias-/", "http://unitatdetuberculosiexperimental.wordpress.com/%22%20%5Ct%20%22_blank", "http://biotech-spain.com/en/directory/capital+cell/", "http://biotech-spain.com/en/articles/tags/covid-19", "http://biotech-spain.com/en/articles/tags/vacuna+ruti%c2%ae", "http://biotech-spain.com/en/articles/tags/capital+cell", "http://biotech-spain.com/en/articles/tags/immuni+therapeutics", "http://biotech-spain.com/en/articles/tags/archivel+farma", "https://capitalcell.es/", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/articles/el-diagn-stico-gen-tico-neonatal-mejora-la-esperanza-de-vida-de-ni-os-con-una-inmunodeficiencia-letal/", "http://biotech-spain.com/en/articles/m-s-de-1-500-cambios-epigen-ticos-en-el-esperma-asociados-a-la-edad-paterna/", "http://biotech-spain.com/en/articles/tuneable-reverse-photochromes-in-the-solid-state-/", "#tab-1", "#tab-2", "http://biotech-spain.com/en/articles/eosin-filos-qu-significa-tener-valores-altos-o-bajos-/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/los-pacientes-con-psoriasis-grave-tienen-mayor-riesgo-cardiovascular/", "http://biotech-spain.com/en/articles/las-pruebas-moleculares-permiten-detectar-de-forma-m-s-eficaz-el-c-ncer-de-endometrio-y-evitar-histerectom-as-innecesarias-en-mujeres-con-sangrado-post-menop-usico/", "http://biotech-spain.com/en/articles/a-study-by-ibs-granada-reveals-that-exposure-to-perfluorinated-compounds-pfas-affects-the-reproductive-health-of-adolescents/", "http://biotech-spain.com/en/articles/key-protein-identified-in-fat-function-and-obesity-related-problems/", "http://biotech-spain.com/en/articles/incliva-y-uv-investigan-la-p-rdida-de-conectividad-entre-el-hipocampo-izquierdo-y-derecho-en-la-enfermedad-de-alzheimer/", "http://biotech-spain.com/en/articles/vhio-led-retrospective-study-evaluates-the-clinical-and-genomic-features-of-early-onset-pancreatic-cancer-/", "http://biotech-spain.com/en/articles/a-portable-sensor-could-detect-cancerous-tumors/", "http://biotech-spain.com/en/articles/tags/cancer", "http://biotech-spain.com/en/articles/tags/covid-19", "http://biotech-spain.com/en/articles/tags/alzheimer", "http://biotech-spain.com/en/articles/tags/investigaci%c3%b3n", "http://biotech-spain.com/en/articles/tags/salud", "http://biotech-spain.com/en/articles/tags/coronavirus", "http://biotech-spain.com/en/articles/tags/covid19", "http://biotech-spain.com/en/terms", "http://biotech-spain.com/en/privacy", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/articles?category=substance-abuse", "http://biotech-spain.com/en/articles?category=agrobiotechnology", "http://biotech-spain.com/en/articles?category=food-sub", "http://biotech-spain.com/en/articles?category=animal-food-feed", "http://biotech-spain.com/en/articles?category=functional-food", "http://biotech-spain.com/en/articles?category=analgesia-pain", "http://biotech-spain.com/en/articles?category=associations", "http://biotech-spain.com/en/articles?category=biobanks", "http://biotech-spain.com/en/articles?category=bioclusters", "http://biotech-spain.com/en/articles?category=biofuels", "http://biotech-spain.com/en/articles?category=biodrugs", "http://biotech-spain.com/en/articles?category=bioinformatics", "http://biotech-spain.com/en/articles?category=cellular-and-molecular-b", "http://biotech-spain.com/en/articles?category=systems-biology", "http://biotech-spain.com/en/articles?category=evolutionary-biology", "http://biotech-spain.com/en/articles?category=synthetic-biology", "http://biotech-spain.com/en/articles?category=biomarkers", "http://biotech-spain.com/en/articles?category=biomaterials", "http://biotech-spain.com/en/articles?category=marine-based-biotechnology", "http://biotech-spain.com/en/articles?category=business-angels", "http://biotech-spain.com/en/articles?category=cancer", "http://biotech-spain.com/en/articles?category=stem-cells", "http://biotech-spain.com/en/articles?category=cardiovascular-and-cir", "http://biotech-spain.com/en/articles?category=research-centers", "http://biotech-spain.com/en/articles?category=private-clinic", "http://biotech-spain.com/en/articles?category=communication-media", "http://biotech-spain.com/en/articles?category=consultancy", "http://biotech-spain.com/en/articles?category=biologic-control-plagues-", "http://biotech-spain.com/en/articles?category=quality-control", "http://biotech-spain.com/en/articles?category=corporate-investor", "http://biotech-spain.com/en/articles?category=cosmetics", "http://biotech-spain.com/en/articles?category=cell-culture", "http://biotech-spain.com/en/articles?category=gm-crops", "http://biotech-spain.com/en/articles?category=biological-defense", "http://biotech-spain.com/en/articles?category=dental", "http://biotech-spain.com/en/articles?category=dermatology", "http://biotech-spain.com/en/articles?category=muskuloskeletal", "http://biotech-spain.com/en/articles?category=biotechnology-kits", "http://biotech-spain.com/en/articles?category=software-development", "http://biotech-spain.com/en/articles?category=diagnostic-imaging", "http://biotech-spain.com/en/articles?category=medical-devices", "http://biotech-spain.com/en/articles?category=drug-delivery", "http://biotech-spain.com/en/articles?category=drug-development", "http://biotech-spain.com/en/articles?category=drug-discovery", "http://biotech-spain.com/en/articles?category=pregnancy-reproduction", "http://biotech-spain.com/en/articles?category=venture-capital-manageme", "http://biotech-spain.com/en/articles?category=energy", "http://biotech-spain.com/en/articles?category=bone-diseases", "http://biotech-spain.com/en/articles?category=chronic-diseases", "http://biotech-spain.com/en/articles?category=degenerative-diseases", "http://biotech-spain.com/en/articles?category=genetic-diseases", "http://biotech-spain.com/en/articles?category=hereditary-diseases", "http://biotech-spain.com/en/articles?category=inflamatory-diseases", "http://biotech-spain.com/en/articles?category=neurologic-diseases", "http://biotech-spain.com/en/articles?category=rares-diseases", "http://biotech-spain.com/en/articles?category=clinical-trials", "http://biotech-spain.com/en/articles?category=public-entity", "http://biotech-spain.com/en/articles?category=epidemiology", "http://biotech-spain.com/en/articles?category=epigenetics", "http://biotech-spain.com/en/articles?category=medical-and-surgica", "http://biotech-spain.com/en/articles?category=patient-monito", "http://biotech-spain.com/en/articles?category=manufacture-of-biotech", "http://biotech-spain.com/en/articles?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=manufacture-o", "http://biotech-spain.com/en/articles?category=manufa", "http://biotech-spain.com/en/articles?category=pharmacy", "http://biotech-spain.com/en/articles?category=pharmacogenomics", "http://biotech-spain.com/en/articles?category=public-financing", "http://biotech-spain.com/en/articles?category=investment-funds", "http://biotech-spain.com/en/articles?category=training", "http://biotech-spain.com/en/articles?category=foundatio", "http://biotech-spain.com/en/articles?category=foundation", "http://biotech-spain.com/en/articles?category=genomics", "http://biotech-spain.com/en/articles?category=hospitals", "http://biotech-spain.com/en/articles?category=infections", "http://biotech-spain.com/en/articles?category=engineering", "http://biotech-spain.com/en/articles?category=immunology", "http://biotech-spain.com/en/articles?category=healthcare-facilities-and", "http://biotech-spain.com/en/articles?category=scientific-t", "http://biotech-spain.com/en/articles?category=inter", "http://biotech-spain.com/en/articles?category=institutional-investor", "http://biotech-spain.com/en/articles?category=private-investor", "http://biotech-spain.com/en/articles?category=leasing", "http://biotech-spain.com/en/articles?category=environmental-cleanup-testing", "http://biotech-spain.com/en/articles?category=maintenance-cell-culture", "http://biotech-spain.com/en/articles?category=sales-marketing", "http://biotech-spain.com/en/articles?category=environment", "http://biotech-spain.com/en/articles?category=metabolomics", "http://biotech-spain.com/en/articles?category=microbiology", "http://biotech-spain.com/en/articles?category=nanotechnology", "http://biotech-spain.com/en/articles?category=neuroscience", "http://biotech-spain.com/en/articles?category=nutrition", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=oftalmology", "http://biotech-spain.com/en/articles?category=cost-optimization", "http://biotech-spain.com/en/articles?category=othe", "http://biotech-spain.com/en/articles?category=peptides", "http://biotech-spain.com/en/articles?category=science-tec", "http://biotech-spain.com/en/articles?category=probiotics", "http://biotech-spain.com/en/articles?category=blood-products", "http://biotech-spain.com/en/articles?category=disposable-medical-prod", "http://biotech-spain.com/en/articles?category=industrial-property-p", "http://biotech-spain.com/en/articles?category=proteins", "http://biotech-spain.com/en/articles?category=proteomics", "http://biotech-spain.com/en/articles?category=dna-tests", "http://biotech-spain.com/en/articles?category=diagnostic-tests", "http://biotech-spain.com/en/articles?category=scientific-publications", "http://biotech-spain.com/en/articles?category=chemistry", "http://biotech-spain.com/en/articles?category=human-resources", "http://biotech-spain.com/en/articles?category=research-network", "http://biotech-spain.com/en/articles?category=r", "http://biotech-spain.com/en/articles?category=animal-health", "http://biotech-spain.com/en/articles?category=women-s-health", "http://biotech-spain.com/en/articles?category=child-health", "http://biotech-spain.com/en/articles?category=mental-health", "http://biotech-spain.com/en/articles?category=senior-health", "http://biotech-spain.com/en/articles?category=healthy", "http://biotech-spain.com/en/articles?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/articles?category=screening", "http://biotech-spain.com/en/articles?category=food-safety", "http://biotech-spain.com/en/articles?category=cro-cmo-services", "http://biotech-spain.com/en/articles?category=research-services-and-supp", "http://biotech-spain.com/en/articles?category=legal-services", "http://biotech-spain.com/en/articles?category=auditory-system", "http://biotech-spain.com/en/articles?category=digestive-system", "http://biotech-spain.com/en/articles?category=kidney-and-geni", "http://biotech-spain.com/en/articles?category=locomotive-system", "http://biotech-spain.com/en/articles?category=metabolic-sy", "http://biotech-spain.com/en/articles?category=central-nervous-system", "http://biotech-spain.com/en/articles?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/articles?category=laser-optical-systems", "http://biotech-spain.com/en/articles?category=cellular-therapy", "http://biotech-spain.com/en/articles?category=gene-therapy", "http://biotech-spain.com/en/articles?category=tissue-therapy", "http://biotech-spain.com/en/articles?category=toxicology", "http://biotech-spain.com/en/articles?category=technology-transfer", "http://biotech-spain.com/en/articles?category=transplant", "http://biotech-spain.com/en/articles?category=universities", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=venture-capital", "http://biotech-spain.com/en/articles?category=vitamins-and-nutri", "http://biotech-spain.com/en/articles?category=viral-vector", "http://biotech-spain.com/en/directory?category=substance-abuse", "http://biotech-spain.com/en/directory?category=agrobiotechnology", "http://biotech-spain.com/en/directory?category=food-sub", "http://biotech-spain.com/en/directory?category=animal-food-feed", "http://biotech-spain.com/en/directory?category=functional-food", "http://biotech-spain.com/en/directory?category=analgesia-pain", "http://biotech-spain.com/en/directory?category=associations", "http://biotech-spain.com/en/directory?category=biobanks", "http://biotech-spain.com/en/directory?category=bioclusters", "http://biotech-spain.com/en/directory?category=biofuels", "http://biotech-spain.com/en/directory?category=biodrugs", "http://biotech-spain.com/en/directory?category=bioinformatics", "http://biotech-spain.com/en/directory?category=cellular-and-molecular-b", "http://biotech-spain.com/en/directory?category=systems-biology", "http://biotech-spain.com/en/directory?category=evolutionary-biology", "http://biotech-spain.com/en/directory?category=synthetic-biology", "http://biotech-spain.com/en/directory?category=biomarkers", "http://biotech-spain.com/en/directory?category=biomaterials", "http://biotech-spain.com/en/directory?category=marine-based-biotechnology", "http://biotech-spain.com/en/directory?category=business-angels", "http://biotech-spain.com/en/directory?category=cancer", "http://biotech-spain.com/en/directory?category=stem-cells", "http://biotech-spain.com/en/directory?category=cardiovascular-and-cir", "http://biotech-spain.com/en/directory?category=research-centers", "http://biotech-spain.com/en/directory?category=private-clinic", "http://biotech-spain.com/en/directory?category=communication-media", "http://biotech-spain.com/en/directory?category=consultancy", "http://biotech-spain.com/en/directory?category=biologic-control-plagues-", "http://biotech-spain.com/en/directory?category=quality-control", "http://biotech-spain.com/en/directory?category=corporate-investor", "http://biotech-spain.com/en/directory?category=cosmetics", "http://biotech-spain.com/en/directory?category=cell-culture", "http://biotech-spain.com/en/directory?category=gm-crops", "http://biotech-spain.com/en/directory?category=biological-defense", "http://biotech-spain.com/en/directory?category=dental", "http://biotech-spain.com/en/directory?category=dermatology", "http://biotech-spain.com/en/directory?category=muskuloskeletal", "http://biotech-spain.com/en/directory?category=biotechnology-kits", "http://biotech-spain.com/en/directory?category=software-development", "http://biotech-spain.com/en/directory?category=diagnostic-imaging", "http://biotech-spain.com/en/directory?category=medical-devices", "http://biotech-spain.com/en/directory?category=drug-delivery", "http://biotech-spain.com/en/directory?category=drug-development", "http://biotech-spain.com/en/directory?category=drug-discovery", "http://biotech-spain.com/en/directory?category=pregnancy-reproduction", "http://biotech-spain.com/en/directory?category=venture-capital-manageme", "http://biotech-spain.com/en/directory?category=energy", "http://biotech-spain.com/en/directory?category=bone-diseases", "http://biotech-spain.com/en/directory?category=chronic-diseases", "http://biotech-spain.com/en/directory?category=degenerative-diseases", "http://biotech-spain.com/en/directory?category=genetic-diseases", "http://biotech-spain.com/en/directory?category=hereditary-diseases", "http://biotech-spain.com/en/directory?category=inflamatory-diseases", "http://biotech-spain.com/en/directory?category=neurologic-diseases", "http://biotech-spain.com/en/directory?category=rares-diseases", "http://biotech-spain.com/en/directory?category=clinical-trials", "http://biotech-spain.com/en/directory?category=public-entity", "http://biotech-spain.com/en/directory?category=epidemiology", "http://biotech-spain.com/en/directory?category=epigenetics", "http://biotech-spain.com/en/directory?category=medical-and-surgica", "http://biotech-spain.com/en/directory?category=patient-monito", "http://biotech-spain.com/en/directory?category=manufacture-of-biotech", "http://biotech-spain.com/en/directory?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=manufacture-o", "http://biotech-spain.com/en/directory?category=manufa", "http://biotech-spain.com/en/directory?category=pharmacy", "http://biotech-spain.com/en/directory?category=pharmacogenomics", "http://biotech-spain.com/en/directory?category=public-financing", "http://biotech-spain.com/en/directory?category=investment-funds", "http://biotech-spain.com/en/directory?category=training", "http://biotech-spain.com/en/directory?category=foundatio", "http://biotech-spain.com/en/directory?category=foundation", "http://biotech-spain.com/en/directory?category=genomics", "http://biotech-spain.com/en/directory?category=hospitals", "http://biotech-spain.com/en/directory?category=infections", "http://biotech-spain.com/en/directory?category=engineering", "http://biotech-spain.com/en/directory?category=immunology", "http://biotech-spain.com/en/directory?category=healthcare-facilities-and", "http://biotech-spain.com/en/directory?category=scientific-t", "http://biotech-spain.com/en/directory?category=inter", "http://biotech-spain.com/en/directory?category=institutional-investor", "http://biotech-spain.com/en/directory?category=private-investor", "http://biotech-spain.com/en/directory?category=leasing", "http://biotech-spain.com/en/directory?category=environmental-cleanup-testing", "http://biotech-spain.com/en/directory?category=maintenance-cell-culture", "http://biotech-spain.com/en/directory?category=sales-marketing", "http://biotech-spain.com/en/directory?category=environment", "http://biotech-spain.com/en/directory?category=metabolomics", "http://biotech-spain.com/en/directory?category=microbiology", "http://biotech-spain.com/en/directory?category=nanotechnology", "http://biotech-spain.com/en/directory?category=neuroscience", "http://biotech-spain.com/en/directory?category=nutrition", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=oftalmology", "http://biotech-spain.com/en/directory?category=cost-optimization", "http://biotech-spain.com/en/directory?category=othe", "http://biotech-spain.com/en/directory?category=peptides", "http://biotech-spain.com/en/directory?category=science-tec", "http://biotech-spain.com/en/directory?category=probiotics", "http://biotech-spain.com/en/directory?category=blood-products", "http://biotech-spain.com/en/directory?category=disposable-medical-prod", "http://biotech-spain.com/en/directory?category=industrial-property-p", "http://biotech-spain.com/en/directory?category=proteins", "http://biotech-spain.com/en/directory?category=proteomics", "http://biotech-spain.com/en/directory?category=dna-tests", "http://biotech-spain.com/en/directory?category=diagnostic-tests", "http://biotech-spain.com/en/directory?category=scientific-publications", "http://biotech-spain.com/en/directory?category=chemistry", "http://biotech-spain.com/en/directory?category=human-resources", "http://biotech-spain.com/en/directory?category=research-network", "http://biotech-spain.com/en/directory?category=r", "http://biotech-spain.com/en/directory?category=animal-health", "http://biotech-spain.com/en/directory?category=women-s-health", "http://biotech-spain.com/en/directory?category=child-health", "http://biotech-spain.com/en/directory?category=mental-health", "http://biotech-spain.com/en/directory?category=senior-health", "http://biotech-spain.com/en/directory?category=healthy", "http://biotech-spain.com/en/directory?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/directory?category=screening", "http://biotech-spain.com/en/directory?category=food-safety", "http://biotech-spain.com/en/directory?category=cro-cmo-services", "http://biotech-spain.com/en/directory?category=research-services-and-supp", "http://biotech-spain.com/en/directory?category=legal-services", "http://biotech-spain.com/en/directory?category=auditory-system", "http://biotech-spain.com/en/directory?category=digestive-system", "http://biotech-spain.com/en/directory?category=kidney-and-geni", "http://biotech-spain.com/en/directory?category=locomotive-system", "http://biotech-spain.com/en/directory?category=metabolic-sy", "http://biotech-spain.com/en/directory?category=central-nervous-system", "http://biotech-spain.com/en/directory?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/directory?category=laser-optical-systems", "http://biotech-spain.com/en/directory?category=cellular-therapy", "http://biotech-spain.com/en/directory?category=gene-therapy", "http://biotech-spain.com/en/directory?category=tissue-therapy", "http://biotech-spain.com/en/directory?category=toxicology", "http://biotech-spain.com/en/directory?category=technology-transfer", "http://biotech-spain.com/en/directory?category=transplant", "http://biotech-spain.com/en/directory?category=universities", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=vaccines", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=venture-capital", "http://biotech-spain.com/en/directory?category=vitamins-and-nutri", "http://biotech-spain.com/en/directory?category=viral-vector"]}